| Mitochondrial modulations, autophagy pathways shifts in viral infections: consequences of COVID-19 SP Singh, S Amar, P Gehlot, SK Patra, N Kanwar, A Kanwal International Journal of Molecular Sciences 22 (15), 8180, 2021 | 27 | 2021 |
| Guanidine-based β amyloid precursor protein cleavage enzyme 1 (BACE-1) inhibitors for the Alzheimer's disease (AD): A review P Gehlot, S Kumar, VK Vyas, BS Choudhary, M Sharma, R Malik Bioorganic & Medicinal Chemistry 74, 117047, 2022 | 17 | 2022 |
| Recent advances on patents of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors as antimalarial agents P Gehlot, VK Vyas Expert Opinion on Therapeutic Patents 33 (9), 579-596, 2023 | 6 | 2023 |
| A patent review of human dihydroorotate dehydrogenase (hDHODH) inhibitors as anticancer agents and their other therapeutic applications (1999-2022) P Gehlot, VK Vyas Recent Patents on Anti-Cancer Drug Discovery 19 (3), 280-297, 2024 | 4 | 2024 |
| 3D-QSAR assisted design, synthesis and pharmacological evaluation of novel substituted benzamides as procaspase-3 activators and anticancer agents G Qureshi, P Gediya, P Gehlot, M Ghate, VK Vyas Journal of Molecular Structure 1286, 135464, 2023 | 4 | 2023 |
| 3D-QSAR-based design, synthesis and biological evaluation of 2, 4-disubstituted quinoline derivatives as antimalarial agents VK Vyas, S Bhati, M Sharma, P Gehlot, N Patel, S Dalai SAR and QSAR in Environmental Research 34 (8), 639-659, 2023 | 4 | 2023 |
| Discovery of Thiadiazoles as Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors by Combined Structure‐Based Modelling Methods P Gehlot, S Kumar, V Kumar, VK Vyas ChemistrySelect 9 (10), e202304077, 2024 | | 2024 |
